StonvexLoading…
StonvexStonvexStonvexCore line items from GEV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.34B | $38.07B | $27.11B | $17.14B |
Operating Income | $179.00M | $1.39B | $787.00M | $421.00M |
Net Income | $4.75B | $4.88B | $1.22B | $768.00M |
EPS (Diluted) | $17.44 | $17.69 | $4.41 | $2.77 |
Total Assets | $75.61B | $63.02B | $54.40B | $53.08B |
Total Liabilities | $60.55B | $50.72B | $44.67B | $43.13B |
Cash & Equivalents | $10.17B | $8.85B | $7.95B | $7.89B |
Free Cash Flow OCF − CapEx | $4.79B | $3.71B | $1.90B | $1.17B |
Shares Outstanding | 268.72M | 269.53M | 271.32M | 272.22M |